In addition, we constructed time‐dependent ROC curves to identify whether survival‐associated SNPs (PSEN1 rs165934 and MAML2 rs76032516) in the presence of clinical variables (ie. age at diagnosis, tumour grade, histology, FIGO stage, residue disease and chemotherapy methods) could better discriminate survival of patients. The gene discussed is MAML2; the disease is neoplasm.